MiMedx Group Inc
NASDAQ:MDXG

Watchlist Manager
MiMedx Group Inc Logo
MiMedx Group Inc
NASDAQ:MDXG
Watchlist
Price: 6.78 USD -2.59% Market Closed
Market Cap: 1B USD

Relative Value

The Relative Value of one MDXG stock under the Base Case scenario is hidden USD. Compared to the current market price of 6.78 USD, MiMedx Group Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

MDXG Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
47
vs Industry
69
Median 3Y
2.7
Median 5Y
2.8
Industry
7.3
Forward
2.6
vs History
9
vs Industry
6
Median 3Y
10.6
Median 5Y
-12.9
Industry
23.3
Forward
26.8
vs History
28
vs Industry
10
Median 3Y
14.5
Median 5Y
-21.1
Industry
19.8
vs History
25
vs Industry
5
Median 3Y
14.8
Median 5Y
-20
Industry
22.6
vs History
85
vs Industry
16
Median 3Y
6
Median 5Y
6.9
Industry
2.7
vs History
50
vs Industry
61
Median 3Y
2.5
Median 5Y
2.6
Industry
7.6
Forward
2.4
vs History
49
vs Industry
61
Median 3Y
3.1
Median 5Y
3.1
Industry
9.4
vs History
50
vs Industry
7
Median 3Y
16.8
Median 5Y
18.2
Industry
4.7
Forward
11.5
vs History
46
vs Industry
7
Median 3Y
18.4
Median 5Y
18.9
Industry
4.8
Forward
19.2
vs History
28
vs Industry
11
Median 3Y
13.1
Median 5Y
-19.5
Industry
5.3
vs History
30
vs Industry
8
Median 3Y
13.3
Median 5Y
-18
Industry
3.8
vs History
63
vs Industry
24
Median 3Y
6.2
Median 5Y
6.6
Industry
5

Multiples Across Competitors

MDXG Competitors Multiples
MiMedx Group Inc Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
US
MiMedx Group Inc
NASDAQ:MDXG
1B USD 2.8 24.9 18.2 20.1
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 917 039.3 -161 202.7 -195 751.4 -193 517.7
US
Abbvie Inc
NYSE:ABBV
344.4B USD 6 82.9 15.7 23.2
US
Amgen Inc
NASDAQ:AMGN
161.5B USD 4.7 27.2 14.6 24
US
Gilead Sciences Inc
NASDAQ:GILD
142.6B USD 5 23.9 10.4 14.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
123.2B USD 11.1 -124.6 26.6 27.8
US
Epizyme Inc
F:EPE
94.1B EUR 2 077.1 -530 -577.1 -561.7
AU
CSL Ltd
ASX:CSL
117.1B AUD 5.1 28.1 17.3 21.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
60.6B USD 4.3 13.5 12 13.5
US
Seagen Inc
F:SGT
39.3B EUR 20 -61.4 -66.1 -59.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
42B USD 17.9 -155.9 -699.4 -350.5
P/E Multiple
Earnings Growth PEG
US
MiMedx Group Inc
NASDAQ:MDXG
Average P/E: 33.4
24.9
9%
2.8
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -161 202.7 N/A N/A
US
Abbvie Inc
NYSE:ABBV
82.9
88%
0.9
US
Amgen Inc
NASDAQ:AMGN
27.2
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
23.9
188%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -124.6 N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -530 N/A N/A
AU
CSL Ltd
ASX:CSL
28.1
16%
1.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
13.5
7%
1.9
US
S
Seagen Inc
F:SGT
Negative Multiple: -61.4 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -155.9 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
MiMedx Group Inc
NASDAQ:MDXG
Average EV/EBITDA: 16.4
18.2
23%
0.8
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -195 751.4 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.7
13%
1.2
US
Amgen Inc
NASDAQ:AMGN
14.6
17%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
10.4
6%
1.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.6
17%
1.6
US
E
Epizyme Inc
F:EPE
Negative Multiple: -577.1 N/A N/A
AU
CSL Ltd
ASX:CSL
17.3
11%
1.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
12
11%
1.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -66.1 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -699.4 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
MiMedx Group Inc
NASDAQ:MDXG
Average EV/EBIT: 20.7
20.1
13%
1.5
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -193 517.7 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.2
29%
0.8
US
Amgen Inc
NASDAQ:AMGN
24
32%
0.8
US
Gilead Sciences Inc
NASDAQ:GILD
14.3
11%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
27.8
17%
1.6
US
E
Epizyme Inc
F:EPE
Negative Multiple: -561.7 N/A N/A
AU
CSL Ltd
ASX:CSL
21.7
14%
1.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
13.5
11%
1.2
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.7 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -350.5 N/A N/A